Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
The market holds massive commercial potential driven by superior clinical outcomes. With ADCs and radioligands leading innovation, it remains oncology’s…